The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Endocrine-responsive breast cancer and strategies for combating resistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,788
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M.-J., & O'Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,932
Histone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P., & Chambon, P. (1986) · Nature · doi:10.1038/320134a0 · Cited by 2,321
ERβ: Identification and characterization of a novel human estrogen receptor
Mosselman, S., Polman, J., & Dijkema, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00782-x · Cited by 2,269
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146
Self-citationA signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Hörlein, A. J., Näär, A. M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Söderström, M., Glass, C. K., et al. (1995) · Nature · doi:10.1038/377397a0 · Cited by 2,034
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Cummings, S. R., Eckert, S., Krueger, K. A., Grady, D., Powles, T. J., Cauley, J. A., Norton, L., Nickelsen, T., Bjarnason, N. H., Morrow, M., et al. (1999) · JAMA · doi:10.1001/jama.281.23.2189 · Cited by 1,872
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
The CBP co-activator is a histone acetyltransferase
Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,805
A transcriptional co-repressor that interacts with nuclear hormone receptors
Chen, J. D., & Evans, R. M. (1995) · Nature · doi:10.1038/377454a0 · Cited by 1,763
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J. M., & Meltzer, P. S. (1997) · Science · doi:10.1126/science.277.5328.965 · Cited by 1,639
Beatson, G. (1896) · The Lancet · doi:10.1016/s0140-6736(01)72384-7 · Cited by 1,608
Chen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M. L., Nakatani, Y., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80516-4 · Cited by 1,465
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000) · Nature · doi:10.1038/35035131 · Cited by 1,436
Tamoxifen in the Treatment of Breast Cancer
Osborne, C. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811263392207 · Cited by 1,320
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
Torchia, J., Rose, D. W., Inostroza, J., Kamei, Y., Westin, S., Glass, C. K., & Rosenfeld, M. G. (1997) · Nature · doi:10.1038/42652 · Cited by 1,283
Beatson, G. (1896) · The Lancet · doi:10.1016/s0140-6736(01)72307-0 · Cited by 1,282
Steroid receptor coactivator-1 is a histone acetyltransferase
Spencer, T. E., Jenster, G., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., McKenna, N. J., Onate, S. A., Tsai, S. Y., Tsai, M.-J., et al. (1997) · Nature · doi:10.1038/38304 · Cited by 1,243
Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase
Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80218-4 · Cited by 1,230
A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression
Heinzel, T., Lavinsky, R. M., Mullen, T.-M., Söderström, M., Laherty, C. D., Torchia, J., Yang, W.-M., Brard, G., Ngo, S. D., Davie, J. R., et al. (1997) · Nature · doi:10.1038/387043a0 · Cited by 1,214
Regulation of Transcription by a Protein Methyltransferase
Chen, D., Ma, H., Hong, H., Koh, S. S., Huang, S.-M., Schurter, B. T., Aswad, D. W., & Stallcup, M. R. (1999) · Science · doi:10.1126/science.284.5423.2174 · Cited by 1,211
ALTERATION OF NUCLEOSOME STRUCTURE AS A MECHANISM OF TRANSCRIPTIONAL REGULATION
Workman, J. L., & Kingston, R. E. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.545 · Cited by 1,129
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
Kousteni, S., Bellido, T., Plotkin, L. I., O'Brien, C. A., Bodenner, D. L., Han, L., Han, K., DiGregorio, G. B., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,113
Estrogen and the Risk of Breast Cancer
Clemons, M., & Goss, P. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101253440407 · Cited by 1,096
Cyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
A two-step mechanism for the interaction of estradiol with rat uterus.
Jensen, E. V., Suzuki, T., Kawashima, T., Stumpf, W. E., Jungblut, P. W., & DeSombre, E. R. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.59.2.632 · Cited by 1,015
Bunone, G., Briand, P. A., Miksicek, R. J., & Picard, D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00571.x · Cited by 986
Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α
Campbell, R. A., Bhat-Nakshatri, P., Patel, N. M., Constantinidou, D., Ali, S., & Nakshatri, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010840200 · Cited by 968
Self-citationMammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 959
AKT plays a central role in tumorigenesis
Testa, J. R., & Bellacosa, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211430998 · Cited by 944
Powles, T. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05071-5 · Cited by 902
Veronesi, U. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04394-3 · Cited by 804
Cummings, S. R. (1999) · Medical Entomology and Zoology · Cited by 797
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
Benz, C. C., Scott, G. K., Sarup, J. C., Johnson, R. M., Tripathy, D., Coronado, E., Shepard, H. M., & Osborne, C. K. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01961241 · Cited by 750
Schwabe, J. W. R., Chapman, L., Finch, J. T., & Rhodes, D. (1993) · Cell · doi:10.1016/0092-8674(93)90390-c · Cited by 750
Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10937 · Cited by 727
CDK-Independent Activation of Estrogen Receptor by Cyclin D1
Zwijsen, R. M. L., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., & Michalides, R. J. A. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81879-6 · Cited by 720
ATP-dependent remodeling and acetylation as regulators of chromatin fluidity
Kingston, R. E., & Narlikar, G. J. (1999) · Genes & Development · doi:10.1101/gad.13.18.2339 · Cited by 702
Basic Guide to the Mechanisms of Antiestrogen Action
Macgregor, J. I., & Jordan, V. C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01358-9 · Cited by 694
Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.
Fantl, V, Stamp, G., Andrews, A., Rosewell, I., & Dickson, C. (1995) · Genes & Development · doi:10.1101/gad.9.19.2364 · Cited by 691
A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization.
Toft, D., & Gorski, J. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.55.6.1574 · Cited by 680
Smith, C. S., Nawaz, Z., & O’Malley, B. W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.657 · Cited by 662
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes.
Lavinsky, R. M., Jepsen, K., Heinzel, T., Torchia, J., Mullen, T.-M., Schiff, R., Del-Rio, A. L., Ricote, M., Ngo, S., Gemsch, J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2920 · Cited by 660 · cited 1×
“Tamoxifen-bound ER interacts with NCORs, resulting in repression of its agonist activit”
BackgroundUK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years
Peto, R., Boreham, J., Clarke, M., Davies, C., & Beral, V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02277-7 · Cited by 648
The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors
Hu, X., & Lazar, M. A. (1999) · Nature · doi:10.1038/47069 · Cited by 644
Dissociation between steroid receptor expression and cell proliferation in the human breast.
Clarke, R. B., Howell, A., Potten, C. S., & Anderson, E. J. (1997) · PubMed · Cited by 625
Mutations truncating the EP300 acetylase in human cancers
Gayther, S. A., Batley, S. J., Linger, L., Bannister, A., Thorpe, K., Chin, S.-F., Daigo, Y., Russell, P., Wilson, A., Sowter, H. M., et al. (2000) · Nature Genetics · doi:10.1038/73536 · Cited by 587
Gordon, D. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92329-1 · Cited by 552
Hormone Receptors: Studies on the Interaction of Estrogen with the Uterus
GORSKI, J., TOFT, D., SHYAMALA, G., SMITH, D., & NOTIDES, A. (1968) · Proceedings of the 1967 Laurentian Hormone Conference · doi:10.1016/b978-1-4831-9827-9.50008-3 · Cited by 530
The SRC family of nuclear receptor coactivators
Leo, C., & Chen, J. D. (2000) · Gene · doi:10.1016/s0378-1119(00)00024-x · Cited by 520
Molecular determinants of nuclear receptor-corepressor interaction
Perissi, V., Staszewski, L. M., McInerney, E. M., Kurokawa, R., Krones, A., Rose, D. W., Lambert, M. H., Milburn, M. V., Glass, C. K., & Rosenfeld, M. G. (1999) · Genes & Development · doi:10.1101/gad.13.24.3198 · Cited by 513
Minireview: Aromatase and the Regulation of Estrogen Biosynthesis—Some New Perspectives
Simpson, E. R., & Davis, S. R. (2001) · Endocrinology · doi:10.1210/endo.142.11.8547 · Cited by 505
Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor.
Ignar-Trowbridge, D. M., Nelson, K. G., Bidwell, M. C., Curtis, S. W., Washburn, T. F., McLachlan, J. A., & Korach, K. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4658 · Cited by 480
ALLEN, E., & DOISY, E. A. (1923) · Journal of the American Medical Association · doi:10.1001/jama.1923.02650100027012 · Cited by 479
Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.
Roger, P., Sahla, M. E., Mäkelä, S., Gustafsson, J. A., Baldet, P., & Rochefort, H. (2001) · PubMed · Cited by 471
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells
Castoria, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.6050 · Cited by 468
Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover.
Dauvois, S., Danielian, P. S., White, R., & Parker, M. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4037 · Cited by 465
Hyperexpression of mitogen-activated protein kinase in human breast cancer.
Sivaraman, V. S., Wang, H., Nuovo, G. J., & Malbon, C. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119309 · Cited by 451
Ogawa, S. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.15.3505 · Cited by 448
Vigushin, D. M., Ali, S., Pace, P., Mirsaidi, N., Ito, K., Adcock, I. M., & Coombes, R. C. (2001) · PubMed · Cited by 447
Self-citationPasqualini, J. R. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.4.1460 · Cited by 433
Klijn, J. G. M., Blamey, R. W., Boccardo, F., Tominaga, T., Duchateau, L., & Sylvester, R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.343 · Cited by 425
Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture.
Lerner, L. J., & Jordan, V. C. (1990) · PubMed · Cited by 417
Mechanism of corepressor binding and release from nuclear hormone receptors
Nagy, L., Kao, H.-Y., Love, J. D., Li, C., Banayo, E., Gooch, J. T., Krishna, V., Chatterjee, K., Evans, R. M., & Schwabe, J. W. R. (1999) · Genes & Development · doi:10.1101/gad.13.24.3209 · Cited by 417
Jacq, X., Brou, C., Lutz, Y., Davidson, I., Chambon, P., & Tora, L. (1994) · Cell · doi:10.1016/0092-8674(94)90404-9 · Cited by 401
The Mammary gland : development, regulation, and function
Neville, M. C., & Daniel, C. W. (1987) · Plenum Press eBooks · Cited by 400
Lau, O. D., Kundu, T. K., Soccio, R. E., Ait-Si-Ali, S., Khalil, E. M., Vassilev, A., Wolffe, A. P., Nakatani, Y., Roeder, R. G., & Cole, P. A. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80452-9 · Cited by 394
Cyclin D1 Stimulation of Estrogen Receptor Transcriptional Activity Independent of cdk4†
Neuman, E., Ladha, M. H., Lin, N., Upton, T. M., Miller, S. J., DiRenzo, J., Pestell, R. G., Hinds, P. W., Dowdy, S. F., Brown, M., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5338 · Cited by 392
Estrogen Receptor Activation Function 1 Works by Binding p160 Coactivator Proteins
Webb, P. (1998) · Molecular Endocrinology · doi:10.1210/me.12.10.1605 · Cited by 384
TRANSCRIPTION ACTIVATION BY ESTROGEN AND PROGESTERONE RECEPTORS
Gronemeyer, H. (1991) · Annual Review of Genetics · doi:10.1146/annurev.ge.25.120191.000513 · Cited by 378
Wang, C., Fu, M., Angeletti, R. H., Siconolfi-Baez, L., Reutens, A. T., Albanese, C., Lisanti, M. P., Katzenellenbogen, B. S., Kato, S., Hopp, T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100800200 · Cited by 366
Kurokawa, H., Lenferink, A. E. G., Simpson, J. F., Pisacane, P. I., Sliwkowski, M. X., Forbes, J. T., & Arteaga, C. L. (2000) · PubMed · Cited by 363
Russo, J., Ao, X., Grill, C., & Russo, I. H. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006186719322 · Cited by 361
Kuukasjärvi, T., Kononen, J., Helin, H., Holli, K., & Isola, J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.9.2584 · Cited by 358
Koh, S. S., Chen, D., Lee, Y.-H., & Stallcup, M. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004228200 · Cited by 358
Estrogen receptors α and β in the rodent mammary gland
Saji, S., Jensen, E. V., Nilsson, S., Rylander, T., Warner, M., & Gustafsson, J.-Å. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.337 · Cited by 357
Sudarsanam, P., & Winston, F. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02060-6 · Cited by 347
pp90rsk1 Regulates Estrogen Receptor-Mediated Transcription through Phosphorylation of Ser-167
Joel, P. B., Smith, J., Sturgill, T. W., Fisher, T. L., Blenis, J., & Lannigan, D. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.1978 · Cited by 345
Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II).
Ing, N. H., Beekman, J. M., Tsai, S. Y., Tsai, M. J., & O'Malley, B. W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37087-5 · Cited by 336
Cross-Talk between Peptide Growth Factor and Estrogen Receptor Signaling Pathways
Smith, C. L. (1998) · Biology of Reproduction · doi:10.1095/biolreprod58.3.627 · Cited by 336
HARPER, M. J. K., & WALPOLE, A. L. (1966) · Nature · doi:10.1038/212087a0 · Cited by 327
Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.
Howe, L. R., Subbaramaiah, K., Brown, A. M., & Dannenberg, A. J. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080097 · Cited by 322
Sun, J., Meyers, M. J., Fink, B. E., Rajendran, R., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1999) · Endocrinology · doi:10.1210/endo.140.2.6480 · Cited by 315
(2012) · SpringerReference · doi:10.1007/springerreference_178251 · Cited by 311
Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1
Zwijsen, R. M. L., Buckle, R. S., Hijmans, E. M., Loomans, C. J. M., & Bernards, R. (1998) · Genes & Development · doi:10.1101/gad.12.22.3488 · Cited by 305
Curtis, S. W., Washburn, T., Sewall, C., DiAugustine, R., Lindzey, J., Couse, J. F., & Korach, K. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12626 · Cited by 304
Zhang, Q., Borg, Å., Wolf, D. M., Oesterreich, S., & Fuqua, S. A. W. (1997) · PubMed · Cited by 291
Chen, D., Riedl, T., Washbrook, E., Pace, P. E., Coombes, R. C., Egly, J.-M., & Ali, S. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00004-3 · Cited by 290
Self-citationHuang, C., Chern, H. D., Chang, K., Cheng, C. W., Hsu, S. M., & Shen, C. (1999) · PubMed · Cited by 289
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions.
Fuqua, S. A. W., Wiltschke, C., ZHANG, Q. X., Borg, Å., Castles, C. G., Friedrichs, W. E., Hopp, T., Hilsenbeck, S. G., Mohsin, S. K., O'Connell, P., et al. (2000) · PubMed · Cited by 278
Järvinen, T. A. H., Pelto-Huikko, M., Holli, K., & Isola, J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64702-5 · Cited by 277
Roodi, N., Bailey, L. R., Kao, W.-Y., Verrier, C. S., Yee, C. J., Dupont, W. D., & Parl, F. F. (1995) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/87.6.446 · Cited by 266
Toward a physiological approach to breast cancer prevention.
Russo, J., & Russo, I. H. (1994) · PubMed · Cited by 260
Phosphorylation of Human Estrogen Receptor α by Protein Kinase A Regulates Dimerization
Chen, D., Pace, P. E., Coombes, R. C., & Ali, S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1002 · Cited by 260
Self-citationThe TRAP/SMCC/Mediator complex and thyroid hormone receptor function
Ito, M., & Roeder, R. G. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00355-6 · Cited by 256
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis
Castoria, G., Barone, M. V., Di Domenico, M., Bilancio, A., Ametrano, D., Migliaccio, A., & Auricchio, F. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2500 · Cited by 253
Estrogen Receptor Expression in Benign Breast Epithelium and Breast Cancer Risk
Khan, S. A., Rogers, M. A. M., Khurana, K. K., Meguid, M. M., & Numann, P. J. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.1.37 · Cited by 251
Gee, J. M. W., Robertson, J. F. R., Ellis, I. O., & Nicholson, R. I. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010720)95:4<247::aid-ijc1042>3.0.co;2-s · Cited by 249
Sande, S. (1996) · Molecular Endocrinology · doi:10.1210/me.10.7.813 · Cited by 236
Weis, K. E. (1996) · Molecular Endocrinology · doi:10.1210/me.10.11.1388 · Cited by 236
LERNER, L. J., HOLTHAUS, F. J., & THOMPSON, C. R. (1958) · Endocrinology · doi:10.1210/endo-63-3-295 · Cited by 233
Martin, M. B., Franke, T. F., Stoica, G. E., Chambon, P., Katzenellenbogen, B. S., Stoica, B. A., McLemore, M. S., Olivo, S. E., & Stoica, A. (2000) · Endocrinology · doi:10.1210/endo.141.12.7836 · Cited by 231
Bautista, S., Valles, H., Walker, R. L., Anzick, S. L., Zeillinger, R., Meltzer, P. S., & Theillet, C. G. (1998) · PubMed · Cited by 231
Selective Estrogen Receptor Modulators: Clinical Spectrum*
Cosman, F., & Lindsay, R. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0371 · Cited by 225
Cunha, G. R., Young, P., Hom, Y. K., Cooke, P. S., Taylor, J. A., & Lubahn, D. B. (1997) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1026303630843 · Cited by 220
Joel, P. B., Traish, A. M., & Lannigan, D. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13317 · Cited by 202
GIBSON, M. K., NEMMERS, L. A., BECKMAN, W. C., DAVIS, V. L., CURTIS, S. W., & KORACH, K. S. (1991) · Endocrinology · doi:10.1210/endo-129-4-2000 · Cited by 198
Estrogen and progesterone receptors in the normal female breast.
Ricketts, D., Turnbull, L. A., Ryall, G., bakhshi, R. K., Rawson, N. S. B., Gazet, J.-C., Nolan, C., & Coombes, R. C. (1991) · PubMed · Cited by 197
Self-citationHormonal Pathogenesis of Adenocarcinoma of the Breast
Lacassagne, A. (1936) · The American Journal of Cancer · doi:10.1158/ajc.1936.217 · Cited by 194
Role of protein methylation in chromatin remodeling and transcriptional regulation
Stallcup, M. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204325 · Cited by 191
Arnold, S. F. (1995) · Molecular Endocrinology · doi:10.1210/me.9.1.24 · Cited by 190
Estrogen Responsiveness and Control of Normal Human Breast Proliferation
Anderson, E., Clarke, R. B., & Howell, A. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018718117113 · Cited by 185
Estrogen receptor beta expression in invasive breast cancer
Mann, S., Laucirica, R., Carlson, N., Younes, P. S., Ali, N., Younes, A., Li, Y., & Younes, M. (2001) · Human Pathology · doi:10.1053/hupa.2001.21506 · Cited by 183
Lange, C. A., Richer, J. K., & Horwitz, K. B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0290 · Cited by 181
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
McMahon, C., Suthiphongchai, T., DiRenzo, J., & Ewen, M. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5382 · Cited by 178
Shim, W.-S., Conaway, M., Masamura, S., Yue, W., Wang, J.-P., Kumar, R., & Santen, R. J. (2000) · Endocrinology · doi:10.1210/endo.141.1.7270 · Cited by 169
Nicholson, R. I., Hutcheson, I. R., Harper, M. E., Knowlden, J. M., Barrow, D., McClelland, R. A., Jones, H. E., Wakeling, A. E., & Gee, J. M. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080175 · Cited by 159
Transcriptional Activators Differ in Their Responses to Overexpression of TATA-Box-Binding Protein
Sadovsky, Y., Webb, P., Lopez, G. N., Baxter, J. D., Fitzpatrick, P. M., Gizang-Ginsberg, E., Cavaillès, V., Parker, M. G., & Kushner, P. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1554 · Cited by 157
Meyers, M. J., Sun, J., Carlson, K. E., Katzenellenbogen, B. S., & Katzenellenbogen, J. A. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990101b · Cited by 137
Microarray and histopathological analysis of tumours: the future and the past?
Lakhani, S. R., & Ashworth, A. (2001) · Nature reviews. Cancer · doi:10.1038/35101087 · Cited by 135
Dotzlaw, H., Leygue, E., Watson, P. H., & Murphy, L. C. (1999) · PubMed · Cited by 134
Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo
METZGER, D., Berry, M., Ali, S., & Chambon, P. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.5.7565805 · Cited by 128
Self-citationLigand‐independent activation of the oestrogen receptor by mutation of a conserved tyrosine
White, R., Sjöberg, M., Kalkhoven, E., & Parker, M. G. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1427 · Cited by 126
Modulating nuclear receptor function: may the phos be with you
Shao, D., & Lazar, M. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7421 · Cited by 120
Inhibitors of histone deacetylase are potentially effective anticancer agents.
Marks, P. A., Rifkind, R. A., Richon, V. M., & Breslow, R. (2001) · PubMed · Cited by 119
Buzdar, A. U., & Howell, A. (2001) · PubMed · Cited by 115
Cohen, L. A., Amin, S., Marks, P. A., Rifkind, R. A., Desai, D. H., & Richon, V. M. (1999) · PubMed · Cited by 112
Coutts, A. S., & Murphy, L. C. (1998) · PubMed · Cited by 110
From ligand to response: generating diversity in nuclear receptor coregulator function
McKenna, N. J., & O’Malley, B. W. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00112-6 · Cited by 102
Lathrop, A. E. C., & Loeb, L. (1916) · PubMed · Cited by 95
Hopp, T. A., & Fuqua, S. A. W. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018726418931 · Cited by 65
INTERACTIONS BETWEEN HORMONES AND CHEMICALS IN BREAST CANCER
Safe, S. H. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.121 · Cited by 52
Turlais, F., Hardcastle, A., Rowlands, M. G., Newbatt, Y. M., Bannister, A. J., Kouzarides, T., Workman, P., & Aherne, G. W. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5340 · Cited by 50
Chan, C. M. W., Lykkesfeldt, A. E., Parker, M. G., et al. (1999) · PubMed · Cited by 45
Cyclic AMP binding proteins and prognosis in breast cancer
Miller, W., Elton, R., Dixon, J. M., Chetty, U., & Watson, D. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.48 · Cited by 30
Estrogen Content and Metabolism in Human Breast Tumor Tissues and Cellsa
CASTAGNETTA, L. A. M., Casto, M. L., Granata, O. M., Polito, L. M., Calabró, M. G., Bue, A. L., Bellavia, V., & Carruba, G. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb16246.x · Cited by 23
Cited by
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032312 · Cited by 1,795
Coombes, R. C., Hall, E., Gibson, L. J., Paridaens, R., Jassem, J., Delozier, T., Jones, S. E., Alvarez, I., Bertelli, G., Ortmann, O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040331 · Cited by 1,759
Self-citationPioneer transcription factors: establishing competence for gene expression
Zaret, K. S., & Carroll, J. S. (2011) · Genes & Development · doi:10.1101/gad.176826.111 · Cited by 1,589
Biological determinants of endocrine resistance in breast cancer
Musgrove, E. A., & Sutherland, R. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2713 · Cited by 1,252
Metadata
- Authors
- Ali, S., & Coombes, R. C.
- Venue
- Nature Reviews Cancer
- Published
- 2002-02
- Volume
- 2
- Issue
- 2
- Pages
- 101-112
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2081491080
- Cited by
- 883
- References
- 152
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.